Bente Glintborg1,2,3, Dorte Vendelbo Jensen4,5, Sara Engel4,3, Lene Terslev4,2,3, Mogens Pfeiffer Jensen2,3, Oliver Hendricks6,7, Mikkel Østergaard2,3, Simon Horskjær Rasmussen3, Thomas Adelsten8, Ada Colic8, Kamilla Danebod3, Malene Kildemand9, Anne Gitte Loft10,11, Heidi Lausten Munk9,12, Jens Kristian Pedersen12,13, René Drage Østgård14, Christian Møller Sørensen15, Niels Steen Krogh16, Jette Nørgaard Agerbo17, Connie Ziegler17, Merete Lund Hetland4,2,3. 1. DANBIO, Rigshospitalet Glostrup, Glostrup, Denmark glintborg@dadlnet.dk. 2. Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Kobenhavn, Denmark. 3. Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet Glostrup, Glostrup, Denmark. 4. DANBIO, Rigshospitalet Glostrup, Glostrup, Denmark. 5. Department of Rheumatology, Center for Rheumatology and Spine Diseases, Gentofte University Hospital, Hellerup, Hovedstaden, Denmark. 6. Danish Hospital for Rheumatology, University of Southern Denmark, Sønderborg, Syddanmark, Denmark. 7. Department of Regional Health Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark. 8. Department of Rheumatology, Sjællands Universitetshospital Køge, Koge, Sjælland, Denmark. 9. Department of Rheumatology, Odense University Hospital, Odense, Denmark. 10. Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark. 11. Department of Clinical Medicine, Health, Aarhus Universitet, Aarhus, Midtjylland, Denmark. 12. Department of Clinical Research, University of Southern Denmark, Odense, Syddanmark, Denmark. 13. Department of Medicine M, Svendborg, Odense University Hospital, Svendborg, Denmark. 14. Diagnostic center, Silkeborg Regional Hospital, Silkeborg, Midtjylland, Denmark. 15. Department of Medicine, Regional Hospital Horsens, Horsens, Midtjylland, Denmark. 16. ZiteLab, Copenhagen, Denmark. 17. Danish Rheumatism Association/Gigtforeningen, Copenhagen, Denmark.
The ongoing COVID-19 pandemic has resulted in widespread shielding in patients with inflammatory rheumatic disease (IRD) due to fear of infection.Work obligations could potentially cause anxiety due to limited possibilities to self-isolate; however, this has only been explored to a limited degree.In this nationwide study including >5000 patients with IRD, we demonstrated widespread concerns related to the work situation mainly in women, biologically treated and patients with poor quality of life.Continuous awareness of the difficult balance between social distancing and work obligations in patients with IRD is important.COVID-19 is a pandemic that has shattered the world, not only once, but with a second wave swiping across the continents. Patients with inflammatory rheumatic diseases (IRDs) have encountered widespread shielding (ie, stringent self-isolation) and poor quality of life (QoL).1–3Work obligations could potentially affect opportunities to self-isolate. The World Health Organization has expressed concerns that some workers may be at higher risk of developing severe COVID-19 illness because of age or pre-existing medical conditions.4 Despite being a topic on the political agenda, in social media and patient organisations, surprisingly little is known regarding the impact of the ongoing pandemic on anxiety and concerns related to the work situation, and in a review of the medical literature, we found no previous research publications regarding patients with IRD.We performed a nationwide online survey in patients with IRD (rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA) and other)1 routinely followed in the Danish DANBIO registry.5 In October–November 2020, patients were invited to answer questions regarding the impact of the second wave of the COVID-19 pandemic on the current work situation and related concerns (see footnote in figure 1), treatment with disease-modifying antirheumatic agents (DMARDs), disease activity, educational level and comorbid diseases.
Figure 1
Concerns related to work situation in 5950 patients with inflammatory arthritis during the COVID-19 pandemic in November 2020. Questions: A: It is important for me to keep physical distance at my job. B: It is difficult for me to keep physical distance at my job. C: My workplace helped to make necessary interventions for me to safely tend my job. D: I fear that my arthritis condition increases my risk of COVID-19 infection at work more than others my age. E: Due to my arthritis condition I should take more precautions at work to avoid infection compared to others my age. F: I am concerned being in the work environment.
Concerns related to work situation in 5950 patients with inflammatory arthritis during the COVID-19 pandemic in November 2020. Questions: A: It is important for me to keep physical distance at my job. B: It is difficult for me to keep physical distance at my job. C: My workplace helped to make necessary interventions for me to safely tend my job. D: I fear that my arthritis condition increases my risk of COVID-19infection at work more than others my age. E: Due to my arthritis condition I should take more precautions at work to avoid infection compared to others my age. F: I am concerned being in the work environment.Demographic and clinical factors associated with work-related concerns were explored with multivariable logistic regression (mostly or completely agree vs other responses) including gender, age (<40/40–60/>60 years), diagnosis (RA/PsA/AxSpA/other), educational level (higher/lower), other comorbidities (yes/no/missing), biological DMARD (bDMARD) treatment (yes/no) and health-related QoL (EQ-5D) (below/above median). Higher educational level was defined as further education for ≥2 years, whereas lower level included vocational training or no further education.Among 14 758 respondents (38% of eligible patients), 5950 patients (40%) were working (60% full time/31% part time/9% self-employed), 61% were female, median age was 55 (IQR 47–60) years, 53% had RA/19% PsA/20% AxSpA/9% other IRD, 53% had higher educational level, 47% reported other comorbidities, 36% received bDMARDs, and self-reported EQ-5D was median 0.80 (IQR 0.74–0.86).Self-reported concerns and anxiety regarding the current work situation were frequent (figure 1, panels A–F) (answers available in 97% of patients). Although 69% (4078/5950 patients) answered that their workplace had helped making arrangements for them to safely tend to their job, 22% (2820/5950) found it difficult (completely/mostly agree) to keep physical distance at work (figure 1, panel B), and 20% (1172/5950) were concerned being in the work environment (figure 1, panel F). Among patients concerned about the work environment, 94% found it important to keep physical distance at work, 75% found it difficult to keep distance, 63% found that their workplace had made necessary interventions, 75% feared that their arthritis increased risk of COVID-19infection at work and 85% felt they should take more precautions than others their age.In multivariable logistic regression analyses including respondents with complete data (n=5878), factors associated with being concerned about being in the work environment were female gender (odds ratio (OR) (95% CI) 1.96 (1.68 to 2.28)), higher educational level (1.34 (1.17 to 1.54)), other comorbidities (yes vs no, 1.37 (1.19 to 1.58)), treatment with bDMARDs (1.46 (1.27 to 1.68)) and poorer EQ-5D (2.71 (2.35 to 3.13)) (all p<0.001). Diagnosis and age were without significance. Similar patterns were found for other work-related concerns (not shown).Potentially, patients with higher education could be more concerned because their work is poorly suited for shielding (eg, working in close physical contact with others (teaching, healthcare, etc)) or they could be more sceptical in general. However, in order to understand the impact of educational level, information regarding specific working activities (eg, manual work, sector of employment) and working conditions such as possibilities to work remotely from home would have been of interest. This was not included in the questionnaire and we could not explore this further.Understanding the impact of COVID-19 on occupational health has high priority,4 6 7 but has previously mainly been explored in certain occupational groups (eg, frontline employees with high SARS-CoV-19 exposure risk8 9) or certain populations10–12 and not specifically in patients with RMD. In accordance with others, our study confirms high anxiety levels related to the work situation, mainly in women,11 persons with poor health conditions9 12 and persons with higher education.7In this study, we included a large cohort of well-characterised patients with IRD who were working during the second wave of the COVID-19 pandemic. Anxiety and concerns related to their work situation were frequent, especially in women, patients receiving biological treatments, those with comorbidities and poor QoL. In the light of the ongoing pandemic and future waves, continuous awareness of the difficult balance between social distancing and work obligations is important.
Authors: Kirsten Nabe-Nielsen; Charlotte Juul Nilsson; Maria Juul-Madsen; Charlotte Bredal; Lars Ole Preisler Hansen; Åse Marie Hansen Journal: Occup Environ Med Date: 2020-10-19 Impact factor: 4.402
Authors: Benjamin Y Q Tan; Nicholas W S Chew; Grace K H Lee; Mingxue Jing; Yihui Goh; Leonard L L Yeo; Ka Zhang; Howe-Keat Chin; Aftab Ahmad; Faheem Ahmed Khan; Ganesh Napolean Shanmugam; Bernard P L Chan; Sibi Sunny; Bharatendu Chandra; Jonathan J Y Ong; Prakash R Paliwal; Lily Y H Wong; Renarebecca Sagayanathan; Jin Tao Chen; Alison Ying Ying Ng; Hock Luen Teoh; Cyrus S Ho; Roger C Ho; Vijay K Sharma Journal: Ann Intern Med Date: 2020-04-06 Impact factor: 25.391
Authors: Anh Kim Dang; Xuan Thi Thanh Le; Huong Thi Le; Bach Xuan Tran; Toan Thi Thanh Do; Hanh Thi Bich Phan; Thao Thanh Nguyen; Quan Thi Pham; Nhung Thi Kim Ta; Quynh Thi Nguyen; Quan Van Duong; Men Thi Hoang; Hai Quang Pham; Trang Ha Nguyen; Linh Gia Vu; Carl A Latkin; Cyrus Sh Ho; Roger C M Ho Journal: Ann Glob Health Date: 2020-09-03 Impact factor: 2.462
Authors: Michael D George; Shilpa Venkatachalam; Shubhasree Banerjee; Joshua F Baker; Peter A Merkel; Kelly Gavigan; David Curtis; Maria I Danila; Jeffrey R Curtis; W Benjamin Nowell Journal: J Rheumatol Date: 2020-11-15 Impact factor: 4.666
Authors: Wanqiu Tan; Fengyi Hao; Roger S McIntyre; Li Jiang; Xiaojiang Jiang; Ling Zhang; Xinling Zhao; Yiran Zou; Yirong Hu; Xi Luo; Zhisong Zhang; Andre Lai; Roger Ho; Bach Tran; Cyrus Ho; Wilson Tam Journal: Brain Behav Immun Date: 2020-04-23 Impact factor: 7.217
Authors: Gabriele Giorgi; Luigi Isaia Lecca; Federico Alessio; Georgia Libera Finstad; Giorgia Bondanini; Lucrezia Ginevra Lulli; Giulio Arcangeli; Nicola Mucci Journal: Int J Environ Res Public Health Date: 2020-10-27 Impact factor: 3.390